Astrana Health, Inc.

NasdaqCM:ASTH 株式レポート

時価総額:US$2.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Astrana Health 将来の成長

Future 基準チェック /36

Astrana Healthは、18.7%と16%でそれぞれ年率18.7%で利益と収益が成長すると予測される一方、EPSはgrowで16.9%年率。

主要情報

18.7%

収益成長率

16.9%

EPS成長率

Healthcare 収益成長19.4%
収益成長率16.0%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日15 Aug 2024

今後の成長に関する最新情報

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Recent updates

Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Aug 02
Astrana Health, Inc.'s (NASDAQ:ASTH) 29% Jump Shows Its Popularity With Investors

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09
Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15
Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25
At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27
With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Nov 08
Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Oct 26
Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Sep 22
Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Aug 04
Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Jul 19
A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Jun 19
We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 05
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20
Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06
Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16
Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical to acquire Valley Oaks Medical Group

Oct 05

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

Sep 26

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Sep 21
A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

Sep 06
The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Aug 22
With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Aug 04

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Aug 04
Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 17
Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

業績と収益の成長予測

NasdaqCM:ASTH - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20262,71797N/A1474
12/31/20252,251801061178
12/31/20241,8186378987
6/30/20241,592685064N/A
3/31/20241,454625266N/A
12/31/20231,387614068N/A
9/30/20231,32845112134N/A
6/30/20231,297466183N/A
3/31/20231,218454666N/A
12/31/20221,144455982N/A
9/30/20221,04558-40-15N/A
6/30/2022955694172N/A
3/31/2022861704884N/A
12/31/2021774695170N/A
9/30/2021756706380N/A
6/30/2021709535765N/A
3/31/2021698476465N/A
12/31/2020687384546N/A
9/30/2020689355252N/A
6/30/2020665224748N/A
3/31/20206301878N/A
12/31/2019561141314N/A
9/30/2019488434N/A
6/30/201949910-11-10N/A
3/31/201949291617N/A
12/31/2018520112425N/A
9/30/2018506284647N/A
6/30/2018436243941N/A
3/31/201839524N/A35N/A
12/31/201735626N/A52N/A
9/30/201733613N/A44N/A
6/30/201732311N/A45N/A
3/31/201731712N/A47N/A
12/31/201630611N/A22N/A
12/31/201531313N/A32N/A
12/31/2014134-1N/A16N/A

アナリストによる今後の成長予測

収入対貯蓄率: ASTHの予測収益成長率 (年間18.7% ) は 貯蓄率 ( 2.5% ) を上回っています。

収益対市場: ASTHの収益 ( 18.7% ) はUS市場 ( 15.1% ) よりも速いペースで成長すると予測されています。

高成長収益: ASTHの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: ASTHの収益 ( 16% ) US市場 ( 8.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: ASTHの収益 ( 16% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: ASTHの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘